These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 34114473)

  • 1. Appropriate use of antimicrobial therapy for COVID-19 co-infection.
    Lai CC; Yu WL
    Immunotherapy; 2021 Sep; 13(13):1067-1070. PubMed ID: 34114473
    [No Abstract]   [Full Text] [Related]  

  • 2. The Elephant in the Room: Secondary Infections and Antimicrobial Use in Patients With COVID-19.
    Ripa M; Mastrangelo A
    Chest; 2021 Aug; 160(2):387-388. PubMed ID: 34366018
    [No Abstract]   [Full Text] [Related]  

  • 3. Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.
    Rawson TM; Moore LSP; Zhu N; Ranganathan N; Skolimowska K; Gilchrist M; Satta G; Cooke G; Holmes A
    Clin Infect Dis; 2020 Dec; 71(9):2459-2468. PubMed ID: 32358954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter analysis of the clinical microbiology and antimicrobial usage in hospitalized patients in the US with or without COVID-19.
    Puzniak L; Finelli L; Yu KC; Bauer KA; Moise P; De Anda C; Vankeepuram L; Sepassi A; Gupta V
    BMC Infect Dis; 2021 Feb; 21(1):227. PubMed ID: 33639862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Could the COVID-19 pandemic aggravate antimicrobial resistance?
    Rossato L; Negrão FJ; Simionatto S
    Am J Infect Control; 2020 Sep; 48(9):1129-1130. PubMed ID: 32603851
    [No Abstract]   [Full Text] [Related]  

  • 6. Improving Antimicrobial Stewardship in Critically-Ill Patients with COVID-19.
    Stevenson DR; Sahemey M; Cevallos Morales J; Martín-Lázaro J; Buchanan R; Serafino Wani R
    Clin Infect Dis; 2021 Jun; 72(11):e926. PubMed ID: 33038229
    [No Abstract]   [Full Text] [Related]  

  • 7. Coronavirus Disease 2019, Superinfections, and Antimicrobial Development: What Can We Expect?
    Clancy CJ; Nguyen MH
    Clin Infect Dis; 2020 Dec; 71(10):2736-2743. PubMed ID: 32361747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 respiratory co-infections: Incidence of viral and bacterial co-pathogens.
    Singh V; Upadhyay P; Reddy J; Granger J
    Int J Infect Dis; 2021 Apr; 105():617-620. PubMed ID: 33640570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased antimicrobial resistance during the COVID-19 pandemic.
    Lai CC; Chen SY; Ko WC; Hsueh PR
    Int J Antimicrob Agents; 2021 Apr; 57(4):106324. PubMed ID: 33746045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial Stewardship in a Pandemic: Picking Up the Pieces.
    Furukawa D; Graber CJ
    Clin Infect Dis; 2021 May; 72(10):e542-e544. PubMed ID: 32857832
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19 pneumonia and the appropriate use of antibiotics.
    Ginsburg AS; Klugman KP
    Lancet Glob Health; 2020 Dec; 8(12):e1453-e1454. PubMed ID: 33188730
    [No Abstract]   [Full Text] [Related]  

  • 12. COVID-19 and Outpatient Parenteral Antimicrobial Therapy.
    Hamad Y; Joynt-Maddox KE; Powderly WG
    Ann Intern Med; 2021 Jan; 174(1):142. PubMed ID: 33460554
    [No Abstract]   [Full Text] [Related]  

  • 13. Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with COVID-19 in Wuhan, China: a retrospective analysis.
    Li J; Wang J; Yang Y; Cai P; Cao J; Cai X; Zhang Y
    Antimicrob Resist Infect Control; 2020 Sep; 9(1):153. PubMed ID: 32962731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of superinfection, antimicrobial usage, and airway microbiome with metagenomic sequencing in COVID-19 patients: A cohort study in Shanghai.
    Miao Q; Ma Y; Ling Y; Jin W; Su Y; Wang Q; Pan J; Zhang Y; Chen H; Yuan J; Wu H; Hu B
    J Microbiol Immunol Infect; 2021 Oct; 54(5):808-815. PubMed ID: 34103263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship.
    Rothe K; Feihl S; Schneider J; Wallnöfer F; Wurst M; Lukas M; Treiber M; Lahmer T; Heim M; Dommasch M; Waschulzik B; Zink A; Querbach C; Busch DH; Schmid RM; Schneider G; Spinner CD
    Eur J Clin Microbiol Infect Dis; 2021 Apr; 40(4):859-869. PubMed ID: 33140176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 and Outpatient Parenteral Antimicrobial Therapy.
    Mathur P
    Ann Intern Med; 2021 Jan; 174(1):141-142. PubMed ID: 33460552
    [No Abstract]   [Full Text] [Related]  

  • 17. Suboptimal antimicrobial stewardship in the COVID-19 era: is humanity staring at a postantibiotic future?
    Owoicho O; Tapela K; Djomkam Zune AL; Nghochuzie NN; Isawumi A; Mosi L
    Future Microbiol; 2021 Aug; 16():919-925. PubMed ID: 34319168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Mystery of Futility of Appropriate Antibiotics for Coinfection in COVID-19.
    Kasugai D; Jingushi N; Omote N; Shindo Y; Goto Y
    Am J Respir Crit Care Med; 2021 Dec; 204(12):1489. PubMed ID: 34546862
    [No Abstract]   [Full Text] [Related]  

  • 19. Meningococcal meningitis and COVID-19 co-infection.
    Gallacher SD; Seaton A
    BMJ Case Rep; 2020 Aug; 13(8):. PubMed ID: 32843469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial Coinfections in COVID-19 Patients without a Positive Microbiologic Result: a Word of Caution.
    Casalini G; Pozza G; Giacomelli A; Antinori S
    Antimicrob Agents Chemother; 2022 Mar; 66(3):e0229621. PubMed ID: 34978885
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.